|
US4099012A
(en)
|
1975-08-28 |
1978-07-04 |
Ciba-Geigy Corporation |
2-pyrazolyl-benzophenones
|
|
US4481142A
(en)
|
1979-02-07 |
1984-11-06 |
Hoffmann-La Roche Inc. |
Pyrimido-2-benzazepines
|
|
NZ192803A
(en)
|
1979-02-07 |
1984-08-24 |
Hoffmann La Roche |
Pyrimido-2-benzazepines and pharmaceutical compositions
|
|
US4469633A
(en)
|
1980-05-16 |
1984-09-04 |
Hoffmann-La Roche Inc. |
N-oxides of 5-oxo-1-phenyl-2-benzazepines
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
EP0273697A3
(en)
|
1986-12-30 |
1989-11-29 |
Merck & Co. Inc. |
2-benzazepines with 5- and 6- membered heterocyclic rings
|
|
IL85035A0
(en)
|
1987-01-08 |
1988-06-30 |
Int Genetic Eng |
Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
|
|
US5166151A
(en)
|
1988-03-25 |
1992-11-24 |
Merck & Co., Inc. |
2-Benzazepines with 5- and 6-membered heterocyclic rings, compositions and medical methods of use thereof
|
|
US5210082A
(en)
|
1991-05-16 |
1993-05-11 |
Merck & Co., Inc. |
2-benzazepines with 5- and 6-membered heterocyclic rings to treat pain and anxiety disorders
|
|
US5736137A
(en)
|
1992-11-13 |
1998-04-07 |
Idec Pharmaceuticals Corporation |
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
|
|
US5747487A
(en)
*
|
1993-07-29 |
1998-05-05 |
American Cyanamid Company |
Tricyclic benzazepine vasopressin antagonists
|
|
US5595721A
(en)
|
1993-09-16 |
1997-01-21 |
Coulter Pharmaceutical, Inc. |
Radioimmunotherapy of lymphoma using anti-CD20
|
|
GB9523675D0
(en)
|
1995-11-20 |
1996-01-24 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
TW486480B
(en)
|
1996-03-08 |
2002-05-11 |
Zeneca Ltd |
Azolobenzazepine derivatives and compositions and method of use thereof
|
|
JP2001507349A
(ja)
|
1996-12-23 |
2001-06-05 |
セルテック セラピューティックス リミテッド |
縮合多環式２−アミノピリミジン誘導体、それらの製造およびたんぱく質チロシンキナーゼ抑制因子としてのそれらの使用
|
|
GB9713087D0
(en)
|
1997-06-20 |
1997-08-27 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
KR100389140B1
(ko)
|
1997-09-29 |
2003-06-25 |
메이지 세이카 가부시키가이샤 |
삼환성 트리아졸로벤즈아제핀 유도체 및 그의 제조방법 및항알레르기제
|
|
US6277844B1
(en)
|
1998-09-14 |
2001-08-21 |
Sydney Spector |
Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis
|
|
US6417207B1
(en)
|
1999-05-12 |
2002-07-09 |
Nitromed, Inc. |
Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
|
|
JP2003513012A
(ja)
*
|
1999-08-11 |
2003-04-08 |
アイデック ファーマスーティカルズ コーポレイション |
抗ｃｄ２０抗体による骨髄病変を伴う非ホジキンリンパ腫を有する患者の治療
|
|
CA2390412A1
(en)
*
|
1999-11-08 |
2001-05-17 |
Idec Pharmaceuticals Corporation |
Treatment of b cell malignancies using anti-cd40l antibodies in combination with anti-cd20 antibodies and/or chemotherapeutics and radiotherapy
|
|
WO2001052353A2
(en)
*
|
2000-01-12 |
2001-07-19 |
Emag Technologies L.L.C. |
Low cost compact omni-directional printed antenna
|
|
WO2001080884A1
(en)
*
|
2000-04-25 |
2001-11-01 |
Idec Pharmaceuticals Corporation |
Intrathecal administration of rituximab for treatment of central nervous system lymphomas
|
|
CA2432799C
(en)
|
2000-12-21 |
2008-08-19 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
US6686352B2
(en)
|
2001-05-18 |
2004-02-03 |
Hoffmann-La Roche Inc. |
Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives
|
|
AU2002328999B8
(en)
|
2001-08-09 |
2008-06-05 |
Actelion Pharmaceuticals Ltd. |
Novel benzo-fused heterocycles as endothelin antagonists
|
|
MY141867A
(en)
|
2002-06-20 |
2010-07-16 |
Vertex Pharma |
Substituted pyrimidines useful as protein kinase inhibitors
|
|
GB0226583D0
(en)
|
2002-11-14 |
2002-12-18 |
Cyclacel Ltd |
Compounds
|
|
BRPI0317717B8
(pt)
|
2002-12-24 |
2021-05-25 |
Astrazeneca Ab |
composto, composição farmacêutica, e uso de um composto
|
|
WO2004071507A1
(en)
|
2003-02-17 |
2004-08-26 |
Pharmacia Italia S.P.A. |
Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
|
GB0315657D0
(en)
|
2003-07-03 |
2003-08-13 |
Astex Technology Ltd |
Pharmaceutical compounds
|
|
TWI372050B
(en)
|
2003-07-03 |
2012-09-11 |
Astex Therapeutics Ltd |
(morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
|
|
US7141568B2
(en)
|
2003-07-09 |
2006-11-28 |
Pfizer Italia S.R.L. |
Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
|
US20050025605A1
(en)
*
|
2003-07-30 |
2005-02-03 |
Vrana John J. |
Locator stud and method of assembly
|
|
SI1663242T1
(sl)
|
2003-08-07 |
2011-09-30 |
Rigel Pharmaceuticals Inc |
2,4-pirimidindiaminske spojine in uporabe kot antiproliferativna sredstva
|
|
CN1897950A
(zh)
|
2003-10-14 |
2007-01-17 |
惠氏公司 |
稠合芳基和杂芳基衍生物及其使用方法
|
|
HRP20080120T5
(hr)
|
2004-05-14 |
2012-07-31 |
Millennium@Pharmaceuticals |
Spojevi i postupci za inhibiciju napredovanja mitoze s pomoću inhibicije aurora kinaze
|
|
JP4812763B2
(ja)
|
2004-05-18 |
2011-11-09 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
シクロアルキル置換ピリミジンジアミン化合物およびそれらの用途
|
|
EP1781653A1
(en)
|
2004-07-05 |
2007-05-09 |
Astex Therapeutics Limited |
3,4-disubstituted pyrazoles as cyclin dependent kinases (cdk) or aurora kinase or glycogen synthase 3 (gsk-3) inhibitors
|
|
ATE485300T1
(de)
|
2004-07-16 |
2010-11-15 |
Sunesis Pharmaceuticals Inc |
Als aurora-kinase-inhibitoren nutzbare thienopyrimidine
|
|
GB2420559B
(en)
|
2004-11-15 |
2008-08-06 |
Rigel Pharmaceuticals Inc |
Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
|
|
WO2006055528A2
(en)
|
2004-11-15 |
2006-05-26 |
Rigel Pharmaceuticals, Inc. |
Process for the preparation of an optically acitive n-carbamate protected beta-lactam by optical resolution employing a candida antarctica lipase
|
|
CA2587427A1
(en)
|
2004-11-17 |
2006-05-26 |
Miikana Therapeutics, Inc. |
Kinase inhibitors
|
|
JP2008526723A
(ja)
|
2004-12-30 |
2008-07-24 |
アステックス、セラピューティックス、リミテッド |
Ｃｄｋ、ｇｓｋ及びオーロラキナーゼの活性を調節するピラゾール誘導体
|
|
JP5507049B2
(ja)
|
2004-12-30 |
2014-05-28 |
アステックス、セラピューティックス、リミテッド |
医薬品
|
|
WO2006070202A1
(en)
|
2004-12-30 |
2006-07-06 |
Astex Therapeutics Limited |
Pyrazole derivatives having kinase modulating activity
|
|
US20080312223A1
(en)
|
2004-12-30 |
2008-12-18 |
Astex Therapeutics Limited |
Thiazole And Isothiazole Derivatives That Modulate The Activity Of CDK, GSK And Aurora Kinases
|
|
US7485661B2
(en)
|
2005-01-18 |
2009-02-03 |
Pfizer Italia S.R.L. |
Heterobicyclic pyrazole derivatives as kinase inhibitors
|
|
US20070104785A1
(en)
*
|
2005-07-29 |
2007-05-10 |
Navale Suryakant V |
Tablets of linezolid form iii and processes for their preparation
|
|
CA2622352C
(en)
|
2005-09-30 |
2014-05-27 |
Miikana Therapeutics, Inc. |
Substituted pyrazole compounds
|
|
WO2007056163A2
(en)
|
2005-11-03 |
2007-05-18 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines useful as kinase inhibitors
|
|
KR20080083680A
(ko)
*
|
2005-12-23 |
2008-09-18 |
스미스클라인 비참 코포레이션 |
오로라 키나제의 아자인돌 억제제
|
|
CN100346830C
(zh)
*
|
2005-12-28 |
2007-11-07 |
上海交通大学医学院附属瑞金医院 |
一种治疗b细胞淋巴瘤的药物组合物
|
|
US7820821B2
(en)
*
|
2006-02-10 |
2010-10-26 |
Transtech Pharma, Inc. |
Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors
|
|
TW200808311A
(en)
|
2006-03-30 |
2008-02-16 |
Nerviano Medical Sciences Srl |
Use of a kinase inhibitor for the treatment of particular resistant tumors
|
|
WO2007132220A1
(en)
|
2006-05-12 |
2007-11-22 |
Cyclacel Limited |
Combination of a 2-substituted-4-heter0aryl-pyrimidine amine with a cytotoxic drug and use thereof in the treatment of a proliferative disorder
|
|
WO2007132221A1
(en)
|
2006-05-12 |
2007-11-22 |
Cyclacel Limited |
Combined anticancer pyrimidine-thiazole aurora kinase inhibitors
|
|
GB0609530D0
(en)
|
2006-05-12 |
2006-06-21 |
Cyclacel Ltd |
Combination
|
|
CA2656393A1
(en)
*
|
2006-06-30 |
2008-01-10 |
Schering Corporation |
Method of using substituted piperidines that increase p53 activity
|
|
EP2054413A2
(en)
*
|
2006-08-09 |
2009-05-06 |
Millennium Pharmaceuticals, Inc. |
Pyridobenzazepine compounds and methods for inhibiting mitotic progression
|
|
CL2007003244A1
(es)
|
2006-11-16 |
2008-04-04 |
Millennium Pharm Inc |
Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
|
|
US20090023743A1
(en)
*
|
2007-05-09 |
2009-01-22 |
Abbott Laboratories |
Inhibitors of protein kinases
|
|
US20090203671A1
(en)
|
2007-11-27 |
2009-08-13 |
Abbott Laboratories |
Method of treating cancer
|
|
WO2009114703A2
(en)
*
|
2008-03-12 |
2009-09-17 |
Fox Chase Cancer Center |
Combination therapy for the treatment of cancer
|
|
WO2010074724A1
(en)
|
2008-12-22 |
2010-07-01 |
Millennium Pharmaceuticals, Inc. |
Combination of aurora kinase inhibitors and anti-cd20 antibodies
|
|
JO3635B1
(ar)
*
|
2009-05-18 |
2020-08-27 |
Millennium Pharm Inc |
مركبات صيدلانية صلبة وطرق لانتاجها
|
|
JO3434B1
(ar)
*
|
2009-07-31 |
2019-10-20 |
Millennium Pharm Inc |
مركبات صيدلانية لمعالجة السرطان وامراض واضطرابات اخري
|
|
EP2496604B1
(en)
*
|
2009-11-06 |
2017-08-23 |
IDEXX Laboratories, Inc. |
Canine anti-cd20 antibodies
|
|
RU2012140021A
(ru)
*
|
2010-02-19 |
2014-03-27 |
Миллениум Фармасьютикалз, Инк. |
КРИСТАЛЛИЧЕСКИЕ ФОРМЫ 4-{[9-ХЛОР-7-(2-ФТОР-6-МЕТОКСИФЕНИЛ)-5Н-ПИРИМИДО[5,4-d][2]БЕНЗАЗЕПИН-2-ИЛ]АМИНО}-2-МЕТОКСИБЕНЗОАТА НАТРИЯ
|